FDA Drug Recalls

Recalls / Generics / Docetaxel Anhydrous

Docetaxel Anhydrous

2 FDA drug recalls involving generic “Docetaxel Anhydrous2 Class I.

DateClassProductFirm
2024-05-28Class IDocetaxel Injection, USP, 160 mg per 16 mL (10 mg per mL), 1 x 16 mL Multi-Dose Vial, Rx only, Mfd. for SagentSagent Pharmaceuticals
2024-05-28Class IDocetaxel Injection, USP, 80 mg per 8 mL (10 mg per mL), 1 x 8 mL Multi-Dose Vial, Rx only, Mfd. for Sagent PhSagent Pharmaceuticals